Autoantibodies Neutralizing Type I INFs May Be Associated with Efficacy of Tocilizumab in COVID-19 Pneumonia.
- Resource Type
- Article
- Source
Journal of Clinical Immunology . Aug2022, Vol. 42 Issue 6, p1107-1110. 4p.- Subject
- *
AUTOANTIBODIES
*TOCILIZUMAB
*COVID-19
*PNEUMONIA
*TYPE I interferons - Language
- ISSN
- 0271-9142